USANA Health Sciences, Inc. (USNA)

Over the past six months, USANA Health Sciences, Inc. stock has experienced a notable decline. As of March 31, 2026, the share price was $17.47, a significant drop from $27.26 on April 1, 2025. The stock dropped 25.6% in the six months leading up to February 2, 2026, and as of April 12, 2026, it has seen a 19.55% decline over the last six months. Key events impacting the stock price include Q3 2025 preliminary results indicating declining profitability, business transition and modernization efforts causing temporary disruptions, lowered guidance, a steep decline suggested by the FY 2026 outlook, and deteriorating investor sentiment.

USANA Health Sciences typically experiences seasonal demand for its products, with management noting that Q3 2025 results were below expectations partly because the company usually sees strong seasonal demand during the third quarter. This is often driven by a "back-to-school push in sales or even just an increase in shopping activity" during this period, suggesting that demand for USANA's products tends to increase in the third quarter of the year.

USANA Health Sciences, Inc. is a global direct-selling company specializing in science-based health and wellness products, developing and manufacturing nutritional supplements, healthy foods, and personal care items. The company operates in the Consumer Non-Cyclicals sector, specifically the Food & Tobacco industry, using a direct selling model to Associates and Preferred Customers. Major products include USANA Nutritionals Optimizers for targeted health needs, Essentials/CellSentials for total body nutrition, food products for weight management and digestive health, and Celavive skincare with USANA InCelligence Technology. The company also offers products for prenatal, infant, and young-child age groups, particularly in China.

USANA Health Sciences, Inc. distributes and sells its products in 25 markets across Asia Pacific and the Americas and Europe. Specific countries include the United States, Canada, Australia, New Zealand, Hong Kong, China, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France, Belgium, Colombia, Indonesia, Germany, Spain, Romania, and Italy.

In the past year, USANA Health Sciences has experienced both positive and negative impacts on its brand reputation. USANA CellSentials earned the ConsumerLab.com Seal of Approval for Purity and Potency, and 190 USANA-sponsored athletes achieved success at the 2026 Winter Olympic Games. CEO Kevin Guest advocated for daily health routines on World Health Day, and Protein Pop Plus launched nationwide at Costco. However, the company's core direct-selling revenues have been declining, and its customer base has shrunk, potentially impacting brand perception.

USANA Health Sciences, Inc. has a diverse ownership structure, including institutional, insider, and individual investors. As of April 9, 2026, there were 123 institutional owners holding a total of 10,512,905 shares, representing 57.88% of the company as of March 31, 2025. Major institutional owners include Renaissance Technologies Llc, Pzena Investment Management Llc, and BlackRock, Inc. Myron W. Wentz, the founder, is the largest individual shareholder, owning 20.29 million shares. Insider ownership is reported to be 41.38%.